# clm_004FA2206A58

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 1,137,422,000 United States dollar  
valid_from: 2015-09-30  
valid_to: 2016-03-31  
published: 2015-11-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A146DEFD4AD2  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 1,137,422,000 United States dollar", as of 2015-09-30 (until 2016-03-31). Claim clm_004FA2206A58, https://asof.is/claim/clm_004FA2206A58, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217615000037/0001532176-15-000037-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-Q Q3 FY2015, filed 2015-11-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217615000037/0001532176-15-000037-index.htm (primary, SEC EDGAR 10-Q Q3 FY2015, published 2015-11-04)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 998,617,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_004FA2206A58](/claim/clm_004FA2206A58.md) | [clm_50CADC50AD04](/claim/clm_50CADC50AD04.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.